
Melissa Jean Perreira
Examiner (ID: 19386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1077 |
| Issued Applications | 495 |
| Pending Applications | 75 |
| Abandoned Applications | 518 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16976257
[patent_doc_number] => 20210220494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => COMPOSITIONS AND METHODS FOR TARGETED PARTICLE PENETRATION, DISTRIBUTION, AND RESPONSE IN MALIGNANT BRAIN TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/095780
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095780 | COMPOSITIONS AND METHODS FOR TARGETED PARTICLE PENETRATION, DISTRIBUTION, AND RESPONSE IN MALIGNANT BRAIN TUMORS | Apr 27, 2017 | Abandoned |
Array
(
[id] => 17497559
[patent_doc_number] => 11286251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Matrix metalloproteinase inhibitors and imaging agents, and methods using same
[patent_app_type] => utility
[patent_app_number] => 16/088868
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 35
[patent_no_of_words] => 19429
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088868
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088868 | Matrix metalloproteinase inhibitors and imaging agents, and methods using same | Apr 6, 2017 | Issued |
Array
(
[id] => 11820451
[patent_doc_number] => 20170209388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'RECONSTITUTED APOLIPOPROTEIN B LIPOPARTICLE, A PREPARATION METHOD AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/481027
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7159
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481027
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481027 | Reconstituted apolipoprotein B lipoparticle, a preparation method and uses thereof | Apr 5, 2017 | Issued |
Array
(
[id] => 12166936
[patent_doc_number] => 09885702
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-02-06
[patent_title] => 'Isotopically-labeled solvents and the use of same in testing E-cigarettes'
[patent_app_type] => utility
[patent_app_number] => 15/473033
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10350
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15473033
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/473033 | Isotopically-labeled solvents and the use of same in testing E-cigarettes | Mar 28, 2017 | Issued |
Array
(
[id] => 11728119
[patent_doc_number] => 20170189562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'Metal Complexes with Bisphosphonate or Pyrophosphate Useful as Imaging Agents'
[patent_app_type] => utility
[patent_app_number] => 15/463688
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5829
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15463688
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/463688 | Metal complexes with bisphosphonate useful as imaging agents | Mar 19, 2017 | Issued |
Array
(
[id] => 11921650
[patent_doc_number] => 09789210
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-10-17
[patent_title] => 'Methods for making ultrasound contrast agents'
[patent_app_type] => utility
[patent_app_number] => 15/461469
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25856
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461469
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/461469 | Methods for making ultrasound contrast agents | Mar 15, 2017 | Issued |
Array
(
[id] => 11980886
[patent_doc_number] => 20170285040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'CA IX - NIR DYES AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 15/461361
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 35063
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461361
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/461361 | CA IX--NIR dyes and their uses | Mar 15, 2017 | Issued |
Array
(
[id] => 13076987
[patent_doc_number] => 10058548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Abuse-proofed dosage form
[patent_app_type] => utility
[patent_app_number] => 15/459180
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 15798
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15459180
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/459180 | Abuse-proofed dosage form | Mar 14, 2017 | Issued |
Array
(
[id] => 19042392
[patent_doc_number] => 11931465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof
[patent_app_type] => utility
[patent_app_number] => 16/083416
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 35666
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083416
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083416 | Functionalized Prussian blue nanoparticles, combination Prussian blue nanoparticle-based nano-immunotherapy and applications thereof | Mar 7, 2017 | Issued |
Array
(
[id] => 13137557
[patent_doc_number] => 10086090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Indocyanine compound, synthesis method and purification method thereof, diagnostic composition using the indocyanine compound, and device for measuring biokinetics and device for visualizing circulation using the diagnostic composition
[patent_app_type] => utility
[patent_app_number] => 15/438047
[patent_app_country] => US
[patent_app_date] => 2017-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 26
[patent_no_of_words] => 20034
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15438047
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/438047 | Indocyanine compound, synthesis method and purification method thereof, diagnostic composition using the indocyanine compound, and device for measuring biokinetics and device for visualizing circulation using the diagnostic composition | Feb 20, 2017 | Issued |
Array
(
[id] => 20157030
[patent_doc_number] => 12383628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Hydrogel-forming composition for controlled release
[patent_app_type] => utility
[patent_app_number] => 15/998916
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 28
[patent_no_of_words] => 22753
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15998916
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/998916 | Hydrogel-forming composition for controlled release | Feb 15, 2017 | Issued |
Array
(
[id] => 11756112
[patent_doc_number] => 20170202980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'METHOD FOR PRODUCING OPTICAL IMAGING CONTRAST AGENT AND OPTICAL IMAGING CONTRAST AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/408974
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7963
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15408974
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/408974 | METHOD FOR PRODUCING OPTICAL IMAGING CONTRAST AGENT AND OPTICAL IMAGING CONTRAST AGENT | Jan 17, 2017 | Abandoned |
Array
(
[id] => 16549722
[patent_doc_number] => 10882871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => 18/19F-labelled compounds which target the prostate specific membrane antigen
[patent_app_type] => utility
[patent_app_number] => 16/068992
[patent_app_country] => US
[patent_app_date] => 2017-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14383
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068992 | 18/19F-labelled compounds which target the prostate specific membrane antigen | Jan 9, 2017 | Issued |
Array
(
[id] => 12466410
[patent_doc_number] => 09987378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Prussian blue-inspired constructs for multimodal imaging and therapy
[patent_app_type] => utility
[patent_app_number] => 15/390106
[patent_app_country] => US
[patent_app_date] => 2016-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 59
[patent_no_of_words] => 10052
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15390106
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/390106 | Prussian blue-inspired constructs for multimodal imaging and therapy | Dec 22, 2016 | Issued |
Array
(
[id] => 14820841
[patent_doc_number] => 10407412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Dimeric contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/060754
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9954
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060754
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060754 | Dimeric contrast agents | Dec 11, 2016 | Issued |
Array
(
[id] => 11962175
[patent_doc_number] => 20170266326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/364678
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 91431
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15364678
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/364678 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | Nov 29, 2016 | Abandoned |
Array
(
[id] => 16743250
[patent_doc_number] => 10968224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => 2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agents
[patent_app_type] => utility
[patent_app_number] => 15/778489
[patent_app_country] => US
[patent_app_date] => 2016-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6233
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778489
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778489 | 2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agents | Nov 24, 2016 | Issued |
Array
(
[id] => 12750931
[patent_doc_number] => 20180142144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => LUMINOGENIC TRANSITION METAL-BASED PYRIDYL COMPLEX AND ITS USE
[patent_app_type] => utility
[patent_app_number] => 15/359736
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/359736 | Luminogenic transition metal-based pyridyl complex and its use | Nov 22, 2016 | Issued |
Array
(
[id] => 11627727
[patent_doc_number] => 20170137916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'METHOD FOR PURIFICATION OF 225AC FROM IRRADIATED 226RA-TARGETS'
[patent_app_type] => utility
[patent_app_number] => 15/359053
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9366
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/359053 | Method for purification of 225AC from irradiated 226RA-targets | Nov 21, 2016 | Issued |
Array
(
[id] => 12151503
[patent_doc_number] => 20180022768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'RADIOACTIVE PHOSPHOLIPID METAL CHELATES FOR CANCER IMAGING AND THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/343604
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 9107
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343604 | RADIOACTIVE PHOSPHOLIPID METAL CHELATES FOR CANCER IMAGING AND THERAPY | Nov 3, 2016 | Abandoned |